Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new clinical trial is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical trial of virtual reality for a mental health disorder. Automated delivery of therapy using VR has potential to transform NHS provision of psychological therapy.

Image shows a person wearing a VR headset with the caption over the image "gameChange, improving lives through VR therapy".

There are currently 220,000 patients diagnosed with schizophrenia in contact with mental healthcare services in the NHS in England and Wales. Two-thirds of these patients have levels of anxious avoidance equivalent to people with agoraphobia.

Daniel Freeman, gameChange lead researcher, Professor of Clinical Psychology, University of Oxford and Consultant Clinical Psychologist, Oxford Health NHS Foundation Trust, said,

"The gameChange VR therapy is for people with conditions such as schizophrenia whose fears have caused them to withdraw to such an extent that everyday tasks – such as getting on a bus, doing the shopping, speaking to other people – are a challenge. It aims to help patients re-engage with the world and go into everyday situations feeling more confident, calm and in control."

VR

 

Over 400 NHS patients across England (Bristol, Manchester, Newcastle, Nottingham and Oxford) will take part in the gameChange clinical trial, which will last 18 months and is funded by the National Institute for Health Research. The purpose of the trial is to find out whether VR therapy works. To do this, half the participants will receive the VR therapy and half will not. A comparison will then be made to see how the people who received VR therapy got on compared to those who did not receive the therapy.

 

Experience from the games industry suggests that VR therapies can also be more enjoyable than traditional treatments – ensuring good take-up and ongoing use of the therapy. The gameChange trial aims to determine whether the promise of success of VR for mental health is true.Professor Daniel Freeman, University of Oxford.

 

This trial is being funded by the NIHR i4i mental health challenge award and it is also supported by the NIHR Oxford Health Biomedical Research Centre.

View a video explaining the gameChange project

For more information visit project website: www.gameChangeVR.com

 

 

 

 

News coverage:

Oxford Mail online

Oxford Times online

This is Oxfordshire

Digitalisationworld.com

Innovatorsmag.com

Nursing Times online

 

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New Study Shows Simvastatin Can Change the Way People Experience Certain Emotions

This new study examines the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Anxiety Disorders Among Children, Assessment and Working with Families

Anxiety disorders are the most common mental health disorders among children, yet there is limited guidance on the process of assessing child anxiety disorders and sharing diagnostic outcomes with families.

Landmark New Clinical Trial Shows Benefits of Automated Virtual Reality (VR) Treatment for Severe Psychological Problems

The gameChange automated VR program is designed to treat agoraphobia in patients with psychosis. In the largest ever clinical trial of virtual reality for mental health, gameChange especially helped people whose anxiety had previously left them virtually housebound.

UK-Japanese Collaboration Researches Mental Health Challenges Faced by Young People and their Families

Dr Simona Skripkauskaite, Departments of Psychiatry and Experimental Psychology, University of Oxford, is the UK lead for one of the ten collaborative research projects jointly awarded by the Economic and Social Research Council (ESRC), the Arts and Humanities Research Council (AHRC) and the Japan Society for the Promotion of Science (JSPS), to address the challenges presented by the global pandemic.

Department of Psychiatry Recognition Awards

Today we announce the prize winners of the first Department of Psychiatry Recognition Awards. One award is designed to offer early career researchers (ECRs) the opportunity to showcase their work, motivations and aspirations for research into mental health. Alongside this we launch the 'Good Citizen' award, where all department members have been able to make nominations.